Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

ALBUTEROL SULFATE INHA

Active
SPE2DP-27-T-0165Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This procurement is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the supply of Albuterol Sulfate Inhalation Aerosol with HFA, identified by NSN 6505015436562. The medication is a prescription-only oral inhalation product where each actuation delivers 108 mcg of Albuterol Sulfate, equivalent to 90 mcg of Albuterol base. The product is supplied in 8.5 gram canisters containing 200 actuations and must be stored at room temperature between 59 and 77 degrees Fahrenheit. The contract specifies a non-extendable shelf life of 24 months and requires delivery within 10 days after order. The procurement includes multiple line items for delivery to various locations, including Fort Stewart, Fort Bragg, and Fort Campbell, with FOB, inspection, and acceptance all set to destination. Suppliers must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1 and MIL-STD-2073-1E. Because the item is regulated by the FDA and classified as hazardous material, contractors must provide Safety Data Sheets and labels compliant with OSHA Hazard Communication Standards. Payment is processed electronically via the Wide Area WorkFlow system. The solicitation also incorporates standard federal clauses regarding the Buy American Act, the Berry Amendment, and cybersecurity requirements for safeguarding covered defense information.

General Info

RFQ for Albuterol Sulfate inhalation aerosols for DLA Troop Support Medical Supply.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

2530 TAYLOR STREET BLDG NUMBER 2530, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

1

RFQ SPE2DP-27-T-0165

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

7 updates
PhaseSolicitation
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
ALBUTEROL SULFATE INHALATION AEROSOL W/H
ALBUTEROL SULFATE INHALATION AEROSOL W/HFA
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. FOR PRESCRIPTION ONLY, FOR ORAL INHALATION. DOSAGE FORMS AND
STRENGTHS: INHALATION AEROSOL: EACH ACTUATION DELIVERS 108 MCG OF
ALBUTEROL SULFATE (ACTIVE INGREDIENT) FROM THE ACTUATOR MOUTHPIECE
(EQUIVALENT TO 90 MCG OF ALBUTEROL BASE).. SUPPLIED IN 8.5 GRAM
CANISTER CONTAINING 200 ACTUATIONS (METERED INHALATIONS). UNIT OF ISSUE
IS EACH
STORAGE: STORE AT ROOM TEMPERATURE BETWEEN 59° F AND 77° F (15° C AND
25° C). AVOID EXPOSURE TO EXTREME HEAT AND COLD. SHAKE THE CANISTER WELL
BEFORE USE. DO NOT PUNCTURE THE CANISTER. DO NOT STORE THE CANISTER NEAR
HEAT OR A FLAME. TEMPERATURES ABOVE 120° F MAY CAUSE THE CANISTER TO
BURST. DO NOT THROW THE CANISTER INTO A FIRE OR AN INCINERATOR. AVOID
SPRAYING IN YOUR EYES.
. LABELING AND MARKING: MUST INCLUDE: NATIONAL STOCK NUMBER MANUFACTURER
DATE OF MANUFACTURER, EXPIRATION DATE OR RETEST DATE CONTRACT NUMBER LOT
NUMBER.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for
SPE2DP-27-T-0165
SECTION B
review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-3174-31 PERRIGO DIRECT INC 9DDF3 P/N NDC45802-0088-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
SPE2DP-27-T-0165
SECTION B
PR: 7018846982 PRLI: 0001 CONT’D
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018846982 0001 EA 1.000
NSN/MATERIAL:6505015436562
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-543-6562 Quantity: 1 EA Purchase Request: 7018846982QTY: 1 Delivery: 10 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
BUPIVACAINE HYDROCHLOR
Solicitation # SPE2DP-27-T-0151
Solicitation SPE2DP-27-T-0151 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Bupivacaine Hydrochloride Injection USP 0.5%, 50 ML (NSN 6505001387347). The requirement consists of two line items with quantities of one and five vials, respectively. The product must be stored at controlled room temperature between 20 to 25 degrees Celsius and carries a non-extendable shelf life of 24 months. Delivery is required within five days of order, with original required delivery dates set for October 26 and 27, 2026. Shipping is FOB Destination, with delivery points located at Fort Campbell, Kentucky, and Rose Barracks, Germany. The contract mandates strict adherence to medical and hazardous material standards. All items must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions. Packaging must be commercial per ASTM D3951 for non-hazardous materials or follow TQ requirement IP025 if the material is deemed hazardous under FED-STD-313. Palletization must comply with DLA requirement RP001. Administrative requirements include electronic invoicing via Wide Area WorkFlow and compliance with the Buy American Act, the Berry Amendment, and various DFARS regulations regarding covered telecommunications equipment and cybersecurity. Inspection and acceptance will occur at the destination.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 2 hours ago

DEADLINE

in 8 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS